What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to publicly disclose preliminary, unaudited financial results for Boston Scientific Corporation's second quarter of 2003 and to provide initial financial guidance (net sales and EPS estimates) for the third quarter, fourth quarter, and the full fiscal year 2003. It serves as a Regulation FD disclosure.

Are the financial results reported in this 8-K final and audited?

No, the financial results reported are preliminary and unaudited. The company uses this 8-K to provide an early look at their performance and future expectations, but final, audited results will be presented in subsequent filings.

Does this filing have the same legal implications as a standard SEC filing?

No, the company explicitly states that the information in this Current Report and its attached exhibit shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section. This means the company is providing the information for disclosure purposes but not assuming the same level of legal responsibility as a formally filed document.

Where can I find the actual financial details for Q2 2003?

The specific preliminary financial results and future estimates are detailed in the press release issued by Boston Scientific Corporation on July 3, 2003, which is attached as Exhibit 99.1 to this 8-K filing. Investors would need to refer to that press release for the numerical data.

BSX 8-K SEC Disclosure

Summary

Boston Scientific Corporation (BSX) filed an 8-K on July 3, 2003, primarily to furnish a press release detailing preliminary, unaudited financial results for the second quarter of 2003. This report also provided initial sales and earnings per share (EPS) estimates for the third quarter, fourth quarter, and the full fiscal year 2003. Investors should note that the information provided is preliminary and unaudited, and the company explicitly states it is not deemed "filed" for purposes of Section 18 of the Exchange Act, meaning it doesn't carry the same liability as a formally filed report.

Key Highlights

1Boston Scientific Corporation (BSX) released preliminary, unaudited Q2 2003 financial results via an 8-K filing.
2The company provided forward-looking estimates for net sales and EPS for Q3 2003, Q4 2003, and the full fiscal year 2003.
3The press release, attached as Exhibit 99.1, serves as the primary disclosure mechanism.
4This 8-K filing is intended to satisfy Regulation FD disclosure requirements.
5The information presented is explicitly stated to not be considered 'filed' under Section 18 of the Securities Exchange Act of 1934, limiting certain legal liabilities.
6The report serves as an update on the company's financial performance and future outlook for the 2003 fiscal year.

BOSTON SCIENTIFIC CORP 8-K Report (Jul 3, 2003)

Summary

Key Highlights

Frequently Asked Questions